E box motifs as mediators of proviral latency of human retroviruses

Retrovirology

Volumn 6, Issue , 2009, Pages 81-

  Terme, Jean Michel ^a   Calvignac, Sébastien ^b   Duc Dodon, Madeleine ^c   Gazzolo, Louis ^c   Jordan, Albert ^a  

^a INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MODEL; E BOX ELEMENT; EDITORIAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; LONG TERMINAL REPEAT; MOLECULAR EVOLUTION; PHYLOGENY; PHYSIOLOGY; PROVIRUS; VIRUS LATENCY;

E-BOX ELEMENTS; EVOLUTION, MOLECULAR; GENE EXPRESSION REGULATION, VIRAL; HIV-1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MODELS, BIOLOGICAL; PHYLOGENY; PROVIRUSES; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

EID: 70349921781     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-81     Document Type: Note

References (28)

1. Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol 2000, 20:429-440. 10.1128/MCB.20.2.429-440.2000, 85097, 10611221.
2. Slattery C, Ryan MP, McMorrow T. E2A proteins: regulators of cell phenotype in normal physiology and disease. Int J Biochem Cell Biol 2008, 40:1431-1436. 10.1016/j.biocel.2007.05.014, 17604208.
3. Kee BL. E and ID proteins branch out. Nat Rev Immunol 2009, 9:175-184. 10.1038/nri2507, 19240756.
4. Ou SH, Garcia-Martinez LF, Paulssen EJ, Gaynor RB. Role of flanking E box motifs in human immunodeficiency virus type 1 TATA element function. J Virol 1994, 68:7188-7199. 237158, 7933101.
5. Zhang Y, Doyle K, Bina M. Interactions of HTF4 with E-box motifs in the long terminal repeat of human immunodeficiency virus type 1. J Virol 1992, 66:5631-5634. 289128, 1501295.
6. Calvignac S, Terme JM, Hensley SM, Jalinot P, Greenwood AD, Hanni C. Ancient DNA identification of early 20th century simian T-cell leukemia virus type 1. Mol Biol Evol 2008, 25:1093-1098. 10.1093/molbev/msn054, 18296697.
7. Calomme C, Dekoninck A, Nizet S, Adam E, Nguyen TL, Broeke A, Willems L, Kettmann R, Burny A, Van Lint C. Overlapping CRE and E box motifs in the enhancer sequences of the bovine leukemia virus 5' long terminal repeat are critical for basal and acetylation-dependent transcriptional activity of the viral promoter: implications for viral latency. J Virol 2004, 78:13848-13864. 10.1128/JVI.78.24.13848-13864.2004, 533944, 15564493.
8. Estable MC, Bell B, Merzouki A, Montaner JS, O'Shaughnessy MV, Sadowski IJ. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996, 70:4053-4062. 190286, 8648743.
9. Imai K, Okamoto T. Transcriptional repression of human immunodeficiency virus type 1 by AP-4. J Biol Chem 2006, 281:12495-12505. 10.1074/jbc.M511773200, 16540471.
10. Terme JM, Wencker M, Favre-Bonvin A, Bex F, Gazzolo L, Duc Dodon M, Jalinot P. Crosstalk between expression of the HTLV-1 Tax transactivator and the oncogenic bHLH transcription factor TAL1. J Virol 2008, 82:7913-22. 10.1128/JVI.02414-07, 2519563, 18495761.
11. Merimi M, Klener P, Szynal M, Cleuter Y, Bagnis C, Kerkhofs P, Burny A, Martiat P, Broeke A. Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: observations in Bovine Leukemia Virus-infected sheep. Retrovirology 2007, 4:51. 10.1186/1742-4690-4-51, 1948017, 17645797.
12. Xu Z, Meng X, Cai Y, Koury MJ, Brandt SJ. Recruitment of the SWI/SNF protein Brg1 by a multiprotein complex effects transcriptional repression in murine erythroid progenitors. Biochem J 2006, 399:297-304. 10.1042/BJ20060873, 1609906, 16800816.
13. Doyle K, Zhang Y, Baer R, Bina M. Distinguishable patterns of protein-DNA interactions involving complexes of basic helix-loop-helix proteins. J Biol Chem 1994, 269:12099-12105.
14. Murre C. Helix-loop-helix proteins and lymphocyte development. Nat Immunol 2005, 6:1079-1086. 10.1038/ni1260, 16239924.
15. O'Neil J, Shank J, Cusson N, Murre C, Kelliher M. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 2004, 5:587-596. 10.1016/j.ccr.2004.05.023, 15193261.
16. Brooks DG, Kitchen SG, Kitchen CM, Scripture-Adams DD, Zack JA. Generation of HIV latency during thymopoiesis. Nat Med 2001, 7:459-464. 10.1038/86531, 11283673.
17. Delassus S, Cheynier R, Wain-Hobson S. Evolution of human immunodeficiency virus type 1 nef and long terminal repeat sequences over 4 years in vivo and in vitro. J Virol 1991, 65:225-231. 240509, 1985198.
18. Delassus S, Meyerhans A, Cheynier R, Wain-Hobson S. Absence of selection of HIV-1 variants in vivo based on transcription/transactivation during progression to AIDS. Virology 1992, 188:811-818. 10.1016/0042-6822(92)90536-X, 1350126.
19. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000, 74:3740-3751. 10.1128/JVI.74.8.3740-3751.2000, 111883, 10729149.
20. Arien KK, Vanham G, Arts EJ. Is HIV-1 evolving to a less virulent form in humans?. Nat Rev Microbiol 2007, 5:141-151. 10.1038/nrmicro1594, 17203103.
21. Van Dooren S, Verschoor EJ, Fagrouch Z, Vandamme AM. Phylogeny of primate T lymphotropic virus type 1 (PTLV-1) including various new Asian and African non-human primate strains. Infect Genet Evol 2007, 7:374-381. 10.1016/j.meegid.2006.06.003, 16931175.
22. Coulthart MB, Posada D, Crandall KA, Dekaban GA. On the phylogenetic placement of human T cell leukemia virus type 1 sequences associated with an Andean mummy. Infect Genet Evol 2006, 6:91-96. 10.1016/j.meegid.2005.02.001, 1983367, 16503510.
23. Zamborlini A, Lehmann-Che J, Clave E, Giron ML, Tobaly-Tapiero J, Roingeard P, Emiliani S, Toubert A, de The H, Saib A. Centrosomal pre-integration latency of HIV-1 in quiescent cells. Retrovirology 2007, 4:63. 10.1186/1742-4690-4-63, 2014762, 17845727.
24. Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF. Experimental approaches to the study of HIV-1 latency. Nat Rev Microbiol 2007, 5:95-106. 10.1038/nrmicro1580, 17224919.
25. Marcello A. Latency: the hidden HIV-1 challenge. Retrovirology 2006, 3:7. 10.1186/1742-4690-3-7, 1379657, 16412247.
26. Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 2007, 7:270-280. 10.1038/nrc2111, 17384582.
27. Ishida T, Hamano A, Koiwa T, Watanabe T. 5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals. Retrovirology 2006, 3:69. 10.1186/1742-4690-3-69, 1617119, 17034647.
28. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A, Matsuoka M. Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2005, 2:64. 10.1186/1742-4690-2-64, 1289293, 16242045.